G. F. X. FEENEY ;
P. FAIRWEATHER
|
2003
Dans Drug and Alcohol Review (Vol.22, n°3, September 2003) Article : Périodique
Dans Drug and Alcohol Review (Vol.22, n°3, September 2003) Article : Périodique
In May 2002 Buprenorphine (Subutex) was listed on the Australian Pharmaceutical Benefits Schedule for treatment in opioid dependence. In addition to broadening treatment options, buprenorphine has the advantage of an improved safety profile. The[...]
Historique